Genetic Signatures

Genetic Signatures Limited – Annual Report 2021 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 30 JUNE 2021 37 Employee Share Ownership Plan Shares Set out below are the summaries of restricted shares and options granted under the plan: 2021 Grant date Exercise price Balance at beginning of the year Number Granted during the year Number Converted during the year Number Expired/ Forfeited during the year Number Balance at the end of the year Number Vested and convertible at year end Number Options October 2016 $0.52 301,250 - (120,250) - 181,000 181,000 November 2016 $0.52 100,000 - - - 100,000 100,000 October 2017 $0.34 387,500 - (62,500) - 325,000 218,750 October 2017 $0.38 250,000 - - - 250,000 187,500 August 2018 $0.53 625,000 - (75,000) - 550,000 230,000 November 2018 $0.53 200,000 - - - 200,000 100,000 February 2019 $0.84 150,000 - - - 150,000 75,000 May 2019 $1.10 200,000 - - 200,000 100,000 November 2019 $0.98 865,000 - (26,000) (30,000) 809,000 190,250 March 2020 $1.13 200,000 - (12,500) (87,500) 100,000 25,000 September 2020 $2.30 - 1,350,000 - (120,000) 1,230,000 - November 2020 $2.30 - 250,000 250,000 - February 2021 $1.88 - 100,000 - (100,000) - - April 2021 $1.56 - 15,000 - - 15,000 - Total 3,278,750 1,715,000 (296,250) (337,500) 4,360,000 1,407,500 Weighted average option exercise price $0.70 $2.27 $0.55 $1.75 $1.25 $0.61 Weighted average remaining contractual life of options (years) 12.96 Financial Report